The goal of this project is to find a series novel biomarkers by differential proteomic techniques that can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate.
Acute respiratory distress syndrome(ARDS) has a very poor prognosis and high mortality. To improve the early diagnosis of ARDS, there is an urgent need for novel biomarkers of ARDS. The goal of this project is to find a series novel biomarkers by differential proteomic techniques that can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate. Clinical data and blood sample were recorded before treatment and after treatment. Acute Physiology And Chronic Health Evaluation III (APACHE III) scores were calculated at enrolment. Studying blood specimens from different period ARDS patients by proteomic analysis. It can provide information on a complex composition of proteins that are differentially expressed, which could be used for discovering high sensitivity and specificity ARDS biomarker.
Study Type
OBSERVATIONAL
Enrollment
500
Xiangya Hospital
Changsha, Hunan, China
Analysis of serum proteins directly by proteomics analysis to identify new biomarkers of ARDS
Time frame: baseline
Analysis of serum proteins directly by proteomics analysis to identify new biomarkers of ARDS
Time frame: 1 month
APACHE III score
Time frame: baseline, 1week, 2 weeks
PaO2/FiO2 ratio
Time frame: baseline, day 3, day 5, 1week, 2 weeks
Mortality or multi-organ failure
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.